Estimating the Return on Investment in Disease Management Programs Using a Pre–Post Analysis
- 1 March 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Disease Management
- Vol. 7 (1) , 5-23
- https://doi.org/10.1089/109350704322918961
Abstract
Disease management programs have become increasingly popular over the past 5-10 years. Recent increases in overall medical costs have precipitated new concerns about the cost-effectiveness of medical management programs that have extended to the program directors for these programs. Initial success of the disease management movement is being challenged on the grounds that reported results have been the result of the application of faulty, if intuitive, methodologies. This paper discusses the use of "pre-post" methodology approaches in the analysis of disease management programs, and areas where application of this approach can result in spurious results and incorrect financial outcome assessments. The paper includes a checklist of these items for use by operational staff working with the programs, and a comprehensive bibliography that addresses many of the issues discussed.Keywords
This publication has 8 references indexed in Scilit:
- Focus On Locus: Evolution Of Medicare’s Local Coverage PolicyHealth Affairs, 2003
- Effect of regression to the mean on decision making in health careBMJ, 2003
- Visualizing Cost-effectiveness AnalysisJAMA, 2002
- The Business Case For QualityHealth Affairs, 2001
- The Financial Impact of Health Promotion and Disease Prevention Programs—Why is it So Hard to Prove Value?American Journal of Health Promotion, 2001
- Heart failure disease management: a critical reviewJournal of Cardiac Failure, 1999
- Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research GroupJAMA, 1996
- Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996